Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Personalised care key to diabetes management, says NICE

December 2, 2015 Research and Development NICE, NICE guidelines, diabetes, type 2 diabetes

UK drugs regulator NICE has published updated guidelines on type 2 diabetes, saying that taking an individualised approach to care …
News
Xalkori

Pfizer lung cancer treatment gets expanded EU approval

December 1, 2015 Research and Development, Sales and Marketing NSCLC, Pfizer, Xalkori, crizotinib, lung cancer, non-small cell lung cancer

Pfizer UK has received European Commission approval for a label update to expand use of Xalkori (crizotinib) to first-line treatment …
News
janssen_scientists

J&J announces new partnerships in fight against HIV/AIDS

December 1, 2015 Research and Development AIDS, HIV, Janssen

Johnson &Johnson is entering four new public-private partnerships aimed at significantly reducing the burden of HIV incidence among young girls …
News
robert-horvitz_large_2

PureTech names Nobel Laureate among new members of scientific advisory board

December 1, 2015 Medical Communications, Research and Development PureTech Health, puretech

PureTech Health has compiled a scientific advisory board of distinguished scientists and physicians to expand its senior team.  The scientific …
Appointment
Medicines Patent Pool

Collaboration between MPP and University of Liverpool targets HIV nanomedicines

December 1, 2015 Manufacturing and Production, Research and Development AIDS, HIV, Medicines Patent Pool, antiretrovirals, nanomedicines

The Medicines Patent Pool (MPP) and the University of Liverpool have agreed a partnership to use the university’s solid drug …
News

Laying bare the complexities of the pricing issue

November 30, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, access, affordability, cost of medicines

Richard Bergström, director general of the European Federation of Pharmaceutical Industry and Associations (EFPIA), on why full transparency in cost discussions …
Feature
robert_k

Ablynx appoints Robert Zeldin as new chief medical officer

November 30, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Ablynx, Robert Zeldin

Ablynx has appointed Dr Robert Zeldin as chief medical officer (CMO) effective from 1 December 2015.  Dr Zeldin will lead …
Appointment
ASH 2014 meeting

Bayer and Novartis to debut new data at ASH 2015

November 30, 2015 Research and Development, Sales and Marketing American Society of Hematology, Bayer, Conference, Novartis, ash, clinical trials, haematology, oncology

Pharma firms will present clinical trial results for the pipeline drugs they are pinning their 2016 hopes for success on, …
News
willy_simon

Willy Simon joins Tiziana as non-executive director

November 27, 2015 Research and Development Tiziana life sciences

Tiziana Life Sciences has appointed Willy Simon as a non-executive director who brings the benefit of a long and successful …
Appointment
michael_linden_300dpi

Pfizer hires new lead for gene therapy research centre

November 26, 2015 Medical Communications, Research and Development Pfizer

Pfizer has hired Professor Michael Linden to lead its new gene therapy research centre in London.  Professor Michael Linden has …
Appointment
praxbind

Boehringer’s Praxbind reversal agent wins EU approval

November 26, 2015 Medical Communications, Research and Development, Sales and Marketing

The European Commission has approved Boehringer Ingelheim’s Praxbind (idarucizumab)- a treatment to rapidly and specifically reverse the anticoagulant effects of …
News
gsk_manufactures_daraprim_for_the_uk_market

Shkreli Daraprim price U-turn prompts renewed fury

November 26, 2015 Medical Communications, Research and Development, Sales and Marketing

Turing CEO Martin Shkreli has sparked yet more criticism, after going back on a pledge to cut the price of …
News
dna

Companies face mixed fortunes in ultra-orphan approvals

November 26, 2015 Medical Communications, Research and Development BioMarin, Duchenne Muscular Dystrophy, FDA, Genzyme, NICE, ultra-orphan drugs

UK regulator NICE has recommended Vimizin, a drug for a very rare genetic disorder, after the manufacturer and NHS England …
Feature
gsk_boronia_australia

GSK begins Phase III study of sirukumab in giant cell arteritis

November 26, 2015 Business Services, Research and Development, Sales and Marketing GSK, Janssen

GSK today announced it has begun a Phase III study evaluating sirukumab, a human anti-interleukin (IL)-6 monoclonal antibody, for the …
News
10_downing_street

UK Spending Review: science budget protected, NHS gets £10 billion boost

November 25, 2015 Research and Development

Feared 40% cuts to the UK’s science budget failed to materialise today, as Chancellor George Osborne announced the budget would …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025